What Researchers Did
Researchers evaluated oxy-inflammation biomarkers in the saliva and urine of nine subjects before and after a technical dive in the Mediterranean Sea.
What They Found
Among the nine subjects, one case of decompression sickness (DCS) occurred during the dive. This injured diver received immediate treatment with oxygen and hyperbaric oxygen therapy (HBOT). The study aimed to evaluate oxy-inflammation biomarkers, but specific results for these were not detailed in the provided abstract.
What This Means for Canadian Patients
Canadian divers should be aware of the risks of decompression sickness (DCS) and the critical importance of immediate treatment, including hyperbaric oxygen therapy (HBOT), if symptoms occur. Prompt medical attention can significantly reduce severe complications and improve outcomes for diving-related injuries.
Canadian Relevance
This study has no direct Canadian connection as it was conducted in the Mediterranean Sea with no Canadian participants or institutions mentioned. However, the findings on decompression sickness are relevant to divers worldwide, including those in Canada.
Study Limitations
A significant limitation of this study is its very small sample size of nine subjects, with only one case of decompression sickness observed.